(Q34986345)

5 August 2017

1 reference

title

Platelets in atherothrombosis. (English)

1 reference

5 August 2017

Zaverio M Ruggeri

1

1 reference

PubMed ID

12411949

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

8

1 reference

5 August 2017

1227-1234

1 reference

5 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1102-1227

5 August 2017

0 references

cites work

Seminars in medicine of the Beth Israel Hospital, Boston. Platelet-endothelium interactions.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

The endothelium and thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Integrin α2-Deficient Mice Develop Normally, Are Fertile, but Display Partially Defective Platelet Interaction with Collagen

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Update on collagen receptor interactions in platelets: is the two-state model still valid?

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

https://api.crossref.org/works/10.1038%2FNM1102-1227

1 reference

7 January 2021

The interaction of fibulin-1 with fibrinogen. A potential role in hemostasis and thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Mechanisms of platelet aggregation.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Thrombin signalling and protease-activated receptors

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Role of thrombin signalling in platelets in haemostasis and thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Characterization of the initial alpha-thrombin interaction with glycoprotein Ib alpha in relation to platelet activation

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Sequential cytoplasmic calcium signals in a 2-stage platelet activation process induced by the glycoprotein Ibalpha mechanoreceptor.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Platelets have more than one binding site for von Willebrand factor

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Functional self-association of von Willebrand factor during platelet adhesion under flow

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE).

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Control of von Willebrand factor multimer size by thrombospondin-1.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Glycoprotein IIb/IIIa antagonism and fibrinolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Clinical trials of glycoprotein IIb/IIIa inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Platelet glycoprotein IIb/IIIa inhibitors: recognition of a two-edged sword?

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Risk factors and outcome of patients with carotid artery stenosis presenting with lacunar stroke. North American Symptomatic Carotid Endarterectomy Trial Group

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Antiplatelet drugs: how to select them and possibilities of combined treatment

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

The management of acute limb ischemia: techniques for dealing with thrombus

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

The role of platelets in peripheral arterial disease: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Atherothrombosis: plaque instability and thrombogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Enhanced shear-induced platelet aggregation in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Platelet collagen receptors and risk prediction in stroke and coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

https://api.crossref.org/works/10.1038%2FNM1102-1227

1 reference

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Platelet-endothelial interactions in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Localized reduction of atherosclerosis in von Willebrand factor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Systemic and local inflammation in patients with unstable atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Induction of platelet thrombi by bacteria and antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Patients with Glanzmann thrombasthenia lacking platelet glycoprotein alpha(IIb)beta(3) (GPIIb/IIIa) and alpha(v)beta(3) receptors are not protected from atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surface.

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Platelet phagocytosis and processing of beta-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1102-1227

7 January 2021

Identifiers

DOI

10.1038/NM1102-1227

1 reference

PubMed ID

12411949

Dimensions Publication ID

5 August 2017

0 references

1 reference

PubMed ID

12411949